Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (14)

2020

  1. Results of an early access treatment protocol of daratumumab monotherapy in spanish patients with relapsed or refractory multiple myeloma

    HemaSphere, Vol. 4, Núm. 3

2015

  1. Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months

    Cancer Medicine, Vol. 4, Núm. 7, pp. 995-1002

2014

  1. Do chronic myeloid leukemia patients with late “warning” responses benefit from “watch and wait” or switching therapy to a second generation tyrosine kinase inhibitor?

    American Journal of Hematology, Vol. 89, Núm. 11, pp. E206-E211

2007

  1. Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients

    Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 12, pp. 1448-1454

2003

  1. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: No differences in cytogenetic responses

    Annals of Hematology, Vol. 82, Núm. 12, pp. 750-758

  2. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051

1998

  1. Tratamiento con interferon alfa linfoblastoide en pacientes con leucemia mieloide crónica resistente a interferon alfa 2 recombinante

    Sangre, Vol. 43, Núm. 5, pp. 443-447

1997

  1. Magnetic resonance imaging features of chloroma of the shoulder

    Skeletal Radiology, Vol. 26, Núm. 1, pp. 70-72

1996

  1. Imipenem combinado con teicoplanina o vancomicina en el tratamiento empírico inicial de la neutropenia febril. Análisis de la respuesta primaria y de una estrategia secuencial global en 126 episodios

    Revista Clinica Espanola, Vol. 196, Núm. 8, pp. 515-522

  2. Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha)

    American Journal of Hematology, Vol. 53, Núm. 3, pp. 169-174

1995

  1. Hypertriglyceridemia may be severe in CML patients treated with interferon‐α

    American Journal of Hematology, Vol. 49, Núm. 3, pp. 240-241

  2. Subacute thyroiditis associated with interferon-α2a therapy [1]

    Hormone and Metabolic Research

  3. TRASPLANTE ALOGENICO DE MEDULO OSEA EN LA LEUCEMIA MIELOIDE CRONICA. RESULTADOS CLINICOS Y FACTORES DE RIESGO EN 70 PACIENTES

    Medicina Clinica, Vol. 105, Núm. 16, pp. 605-611

1994

  1. INFECCIONES BACTERIANAS PRECOCES EN 103 PACIENTES TRATADOS CON TRASPLANTE DE MEDULA OSEA

    Sangre, Vol. 39, Núm. 3, pp. 191-196